drugset
drugset / Trial / NCT04082000

Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy

NCT04082000 ↗

Phase 1/2 Terminated 2 enrolled Breath of Life International Pharma Ltd
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy

Timeline

Start
2019-04-15
Primary completion
2020-11-04
Completion
2020-11-04

Outcome

Outcome not reported

Stopped (Business): “study stopped due to company strategic prioritization”

Drugs

EvaluationDrugModalityDoseRoute
Subject BOL-DP-o-04 Unknown — Other

Indications

diabetic neuropathy